BUBS Australia Ltd (ASX: BUB) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

BUBS Australia Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $111.77 million
P/E Ratio 20.16
Dividend Yield 0.00%
Shares Outstanding 894.13 million
Earnings per share 0.006
Dividend per share N/A
Year To Date Return -9.09%
Earnings Yield 4.96%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • BUBS Australia Ltd (ASX: BUB)
    Latest News

    a woman
    Growth Shares

    2 ASX shares poised for huge growth in 2020

    These 2 ASX small cap shares are poised to unveil huge growth in 2020, including Pushpay Holdings Ltd (ASX:PPH).

    Read more »

    a woman
    Share Market News

    Why the Synlait Milk share price on watch today

    The Synlait Milk Ltd (ASX: SM1) share price is one to watch this morning after the Kiwi dairy group increased…

    Read more »

    a woman
    Capital Raising

    ASX infant formula group Wattle Health to raise $39.7 million in new shares

    ASX infant formula company Wattle Health Australia (ASX: WHA) is looking to raise $39.7 million in new shares in the…

    Read more »

    a woman
    Growth Shares

    3 ASX small caps that should be in your portfolio for the 2020s

    These 3 ASX small caps, including Bubs Australia Ltd (ASX:BUB), should be in your portfolio for the 2020s.

    Read more »

    a woman
    Share Market News

    3 top ASX growth shares to diversify your portfolio

    Here's why A2 Milk Company (ASX: A2M) and these other 2 top ASX growth shares are my picks for a…

    Read more »

    a woman
    Share Market News

    3 ASX growth shares to buy and hold beyond 2025

    Here's why I think these 3 ASX growth shares are great options to buy and hold until 2025 and beyond.

    Read more »

    a woman
    Share Gainers

    Is this infant formula company the next a2 Milk Company?

    Is Nuchev Limited (ASX:NUC) the next A2 Milk Company Ltd (ASX:A2M)?

    Read more »

    a woman
    ⏸️ Growth Investing

    Can ASX infant formula shares soar in 2020?

    The ASX infant formula shares have been climbing higher in recent years, but what will a new decade mean for…

    Read more »

    a woman
    Share Market News

    3 ASX companies to watch in 2020

    These 3 ASX companies that have already laid solid foundations for future growth – so much so that 2020 might…

    Read more »

    a woman
    Share Market News

    Top brokers name 3 ASX shares to buy right now

    Bubs Australia Ltd (ASX:BUB) shares are one of three that top brokers have named as buys this month...

    Read more »

    a woman
    ⏸️ ASX Shares

    3 ASX shares of the year

    I think these three ASX shares could be called shares of the year, including City Chic Collective Ltd (ASX:CCX).

    Read more »

    a woman
    Share Market News

    Can the a2 Milk success story continue in 2020?

    The A2 Milk Company Ltd (ASX: A2M) share price has been growing at a very impressive rate and there are…

    Read more »

    Frequently Asked Questions

    No, Bubs Australia does not pay dividends at this stage.

    Bubs Australia Ltd listed on the ASX on 5 October 1993.

    BUB ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About BUBS Australia Ltd

    Bubs Australia Ltd (ASX: BUB) is a producer of infant nutrition products. The company offers a range of infant formulas including organic grass-fed cows' milk and goat milk products, as well as organic baby food, nutritional supplements, and cereals.

    Bubs Australia is also a major Australian supplier of goat milk and goat milk powder for both the infant and adult markets.

    The company's products are widely sold in supermarkets and pharmacies in Australia and exported to China, Southeast Asia, and the Middle East. 

    BUB Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    06 Feb 2026 $0.13 $0.00 0.00% 856,174 $0.13 $0.13 $0.13
    05 Feb 2026 $0.13 $0.00 0.00% 115,642 $0.13 $0.13 $0.13
    04 Feb 2026 $0.13 $-0.01 -7.69% 956,620 $0.14 $0.14 $0.13
    03 Feb 2026 $0.13 $0.00 0.00% 112,904 $0.13 $0.13 $0.13
    02 Feb 2026 $0.13 $-0.01 -7.41% 256,855 $0.13 $0.14 $0.13
    30 Jan 2026 $0.14 $-0.01 -7.14% 2,708,667 $0.14 $0.14 $0.13
    29 Jan 2026 $0.14 $0.01 7.41% 2,796,224 $0.14 $0.14 $0.13
    28 Jan 2026 $0.14 $-0.01 -7.14% 1,291,204 $0.14 $0.14 $0.13
    27 Jan 2026 $0.14 $0.01 7.41% 972,264 $0.14 $0.14 $0.13
    23 Jan 2026 $0.14 $0.01 7.69% 1,034,364 $0.13 $0.14 $0.13
    22 Jan 2026 $0.13 $-0.01 -7.41% 1,365,835 $0.14 $0.14 $0.13
    21 Jan 2026 $0.14 $0.00 0.00% 104,952 $0.14 $0.14 $0.14
    20 Jan 2026 $0.14 $0.00 0.00% 376,703 $0.14 $0.14 $0.14
    19 Jan 2026 $0.14 $0.00 0.00% 133,344 $0.14 $0.14 $0.14
    16 Jan 2026 $0.14 $0.00 0.00% 114,431 $0.14 $0.14 $0.14
    15 Jan 2026 $0.14 $0.00 0.00% 412,174 $0.14 $0.14 $0.14
    14 Jan 2026 $0.14 $-0.01 -7.14% 488,096 $0.15 $0.15 $0.14
    13 Jan 2026 $0.14 $0.00 0.00% 451,547 $0.14 $0.14 $0.14
    12 Jan 2026 $0.14 $0.01 7.41% 1,117,229 $0.14 $0.14 $0.14
    09 Jan 2026 $0.14 $-0.01 -7.14% 334,561 $0.14 $0.14 $0.14

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    21 Nov 2025 Joe Coote Issued 7,132,645 $998,570
    Issue of securities. 7,132,645 Performance Rights
    17 Sep 2025 Paul Jensen Buy 130,890 $18,979
    On-market trade.
    15 Sep 2025 Paul Jensen Buy 500,000 $81,000
    On-market trade.
    07 Mar 2025 Paul Jensen Buy 40,000 $5,000
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Paul David Kristian Jensen Non-Executive Director Mar 2023
    Mr Jensen brings perspectives drawn from his professional career. Paul is based in Sydney, Australia. Paul has more than 20 years of Board experience as a professional director with both ASX listed, public and private corporations across consumer goods, equity capital markets, banking, government, philanthropy, and indigenous affairs. He brings an international perspective gained from an executive career working in New Zealand, Australia, and the United Kingdom. He currently holds the position of Non-Executive Director and Treasurer for the Australia Made Campaign Limited, which on behalf of the Australian Government administers the highly recognized and trusted Australian Made and ReMade in Australia trademarks, he is a Director of Alterra Limited and GNS Wholesale Limited. Paul is a Fellow of The Australian Institute of Company Directors. He is Chair of the Risk Committee .
    Mr Steve Lin Non-Executive Director Apr 2019
    Mr Lin currently serves on the Board of three North American consumer products companies, Stella & Chewy's, a pet food company in the US, Petcurean a pet food company in Canada and China and KDC/ONE, OEM/ ODM manufacturers in beauty, personal care and home care. A highly experienced board director, Steve has been doing business in China for 30 years including serving on company and university boards. Steve also has more than 25 years of investment, operations, and management experience in Asia and the US. For the last 7 years Steve has been Managing Partner for C2 Capital, a private equity firm focused on investing in leading consumer products to provide growth capital to scale in the China market. Prior to joining C2 Capital, Steve worked for Morgan Stanley, Goldman Sachs, GMAC Commercial Holding Corp (subsequently, Capmark Financial Group) and Laureate Education in New York, Hong Kong and Tokyo. Steve co-founded a non-profit organization, Hands On Tokyo, and previously served on the Board of Directors of Xi'an Jiaotong-Liverpool University and Hunan International Economics University.
    Mr Joe Coote Chief Executive OfficerExecutive Director Jul 2025
    Mr Coote is an international executive with over 20 years of leadership in the FMCG, dairy and infant nutrition sectors. Most recently he was the CEO of Darigold. Prior to that Mr Coote spent 12 years at Fonterra in senior roles commercial operations across the USA, Asia, and ANZ culminating in President, Fonterra Americas.
    Mr Peter Cope General CounselCompany Secretary Jan 2025
    -
    Naomi Verloop Chief Financial Officer
    -
    Richard Paine Chief Operating Officer
    -
    Peter Cope General CounselCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    C2 Capital Global Export-To-China Fund 76,288,510 8.54%
    Ataturk Investments Pty Ltd 37,758,682 4.23%
    HSBC Custody Nominees (Australia) Limited 30,607,079 3.43%
    Citicorp Nominees Pty Limited 26,964,550 3.02%
    J P Morgan Nominees Australia Pty Limited 19,044,000 2.13%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 16,996,027 1.90%
    Mr Jianlin Zhou 7,058,000 0.79%
    Mr Benjamin Paul Landon 7,001,271 0.78%
    Boom Securities (Hk) Limited <Clients Account> 6,732,561 0.75%
    Keong Lim Pty Limited <Sk Lim Family A/C> 5,346,000 0.60%
    Costa Asset Management Pty Ltd <Costa Asset Mgmt Unit A/C> 5,200,000 0.58%
    BNP Paribas Nominees Pty Ltd <Clearstream> 4,778,012 0.53%
    Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 4,674,559 0.52%
    Stable Charter Limited 4,615,385 0.52%
    Mr Xin Fan 4,400,000 0.49%
    Ms Liying Wang 4,200,000 0.47%
    Mr Jun Hua Chen 4,000,000 0.45%
    Intercontinental Pty Limited 4,000,000 0.45%
    Ms Zhaochu Yuan 3,982,846 0.45%
    Mr Xi Liu 3,977,363 0.45%

    Profile

    since

    Note